Back to search results

Observational Study of Endoscopic Ultrasound Radiofrequency Ablation for Pancreatic Neoplasms

This study is creating a database to collect information about a procedure called endoscopic ultrasound radiofrequency ablation (EUS-RFA). EUS-RFA uses heat to treat tumors or enlarged lymph nodes (adenopathy) in the pancreas. Doctors at Indiana University are performing these procedures as part of your standard care. This study will gather data from your electronic medical records, including details about your condition before the procedure, lab results, the EUS-RFA procedure itself, and your follow-up care. You may be eligible if you are 14 years or older and have been referred for treatment of a tumor or adenopathy. The study aims to track any complications during the procedure and symptoms like abdominal pain or fever for up to two weeks afterward. The current recruitment status is unclear.

Study design
This is an observational study, meaning researchers will collect information from existing medical records. There is no specified phase for this study, and it plans to include 100 participants.
What's involved
No additional clinical procedures will be performed beyond your current standard of care for endoscopic ultrasound. You will have already signed an informed consent for the endoscopic ultrasound.
Compensation
Not stated in the trial record.
Follow-up
Your information will be entered into the database for up to 10 years after your most recent procedure. Symptoms related to the procedure will be tracked for up to 2 weeks following the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04693754

Endoscopic Ultrasound Radiofrequency Ablation, Database Repository

Enrolling by Invitation
Not specifiedAges 14+Observational
Indiana University
~100 participants
Updated 2026-02-18 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Incidence of any procedural complications that occur during the procedure on date of procedure.
Measured over Day of procedure
+2 more outcomes measured

Conditions

Pancreatic Neoplasm

Explore related trials

Pancreatic Neoplasm

Where it's being run

1 sites across 1 states
Indiana1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Subjects less than 14 years of age Unable to comprehend the study consent due to language or disability

What this trial measures

  • Incidence of any procedural complications that occur during the procedure on date of procedure.Day of procedure

    This data will be used for to determine the clinical impact and safety of these procedures.

  • Rate of patient report of symptoms related to procedure (Acute pancreatitis, abdominal pain, infection/abscess, venous thrombosis, & fever)1 week following procedure

    1 week phone follow up

  • Rate of patient report of symptoms related to procedure (Acute pancreatitis, abdominal pain, infection/abscess, venous thrombosis, & fever)2 weeks following procedure

    2 week phone follow up